ReviewBMJ global health2025
Seasonal influenza surveillance and vaccination policies in the WHO South-East Asian Region.
Review in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Effectiveness of a trivalent inactivated split-virion influenza vaccine (Tri Fluvac) in Thailand: a phase IV test-negative case-control study.The Lancet regional health. Southeast Asia · 2026Article
- Improving Influenza Vaccine Uptake in Low- and Lower-Middle-Income Countries: A Synthesis of Interventions and Strategic Recommendations.Open forum infectious diseases · 2026Review
- Article
- Article
- A scoping review of influenza RdRp-targeting inhibitors: mechanisms, clinical translation, and emerging challenges.Frontiers in microbiology · 2026Review
- Article
- Integrating Surveillance and Stakeholder Insights to Predict Influenza Epidemics: A Bayesian Network Study in Queensland, Australia.International journal of environmental research and public health · 2026Article
- Seasonal Influenza Vaccination Uptake and Intentions Among Nursing Students in Hong Kong.Vaccines · 2025Article
- A cluster randomised trial of digital messaging nudges to improve influenza vaccination uptake in China.NPJ digital medicine · 2025Article
- Effect of Influenza Vaccination on Mortality and Heart Failure Hospitalization in Heart Failure Patients.Vaccines · 2025Article
- Influenza surveillance and vaccine policy in Thailand-a historical perspective.The Lancet regional health. Southeast Asia · 2025Review
- Temporal trends and forecasting of respiratory mortality in Bangladesh: A SARIMA model for seasonal mortality risk and public health action.Journal of public health research · 2025Article
- Addressing influenza in Bangladesh: closing evidence and policy gaps with strategic interventions.The Lancet regional health. Southeast Asia · 2025Review
- Analysis of influenza-like illness trends in Saudi Arabia: a comparative study of statistical and deep learning techniques.Osong public health and research perspectives · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The WHO South-East Asia Region (SEAR), with its high population density, is recognised by epidemiologists as a critical reservoir for the emergence and global dissemination of novel influenza strains, making it a potential epicentre for future influenza pandemics. Despite this significant risk, most SEAR countries lack comprehensive seasonal influenza vaccination policies, resulting in low vaccine uptake across the region. This review analysed the latest WHO National Influenza Programme factsheets from the 11 SEAR member states and supplemented this with extensive manual literature searches using electronic databases and government websites. As of October 2022, only three countries-India, Bhutan and Thailand-had established seasonal influenza vaccination policies. Among them, Bhutan and Thailand have policies that cover all five WHO-recommended high-risk groups. While national influenza surveillance systems are in place across SEAR, only India and the Democratic People's Republic of Korea claim full population coverage. Influenza vaccine production capacity is limited to Bangladesh, India and Indonesia. The region's varied climatic conditions and insufficient local data have further obscured the true burden of influenza. Thailand offers a successful model for other countries in the region, beginning with the most vulnerable groups and gradually expanding coverage. To effectively develop and implement national influenza vaccination policies, SEAR countries must close the evidence gap by strengthening surveillance systems to provide accurate, timely data and prioritise context-specific research, leverage existing vaccine infrastructure, enhance public education and finally engage with local and international stakeholders to establish strong international cooperation to support these efforts and improve pandemic preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.